.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Accenture
Chubb
Dow
Julphar
Fish and Richardson
Fuji
Daiichi Sankyo
Deloitte
Federal Trade Commission

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006882

« Back to Dashboard
NDA 006882 describes PHISOHEX, which is a drug marketed by Sanofi Aventis Us and is included in two NDAs. It is available from one supplier. Additional details are available on the PHISOHEX profile page.

The generic ingredient in PHISOHEX is hexachlorophene. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hexachlorophene profile page.

Summary for 006882

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 006882

Medical Subject Heading (MeSH) Categories for 006882

Suppliers and Packaging for NDA: 006882

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PHISOHEX
hexachlorophene
EMULSION;TOPICAL 006882 NDA sanofi-aventis U.S. LLC 0024-1535 0024-1535-02 148 mL in 1 BOTTLE, PLASTIC (0024-1535-02)
PHISOHEX
hexachlorophene
EMULSION;TOPICAL 006882 NDA sanofi-aventis U.S. LLC 0024-1535 0024-1535-06 473 mL in 1 BOTTLE, PLASTIC (0024-1535-06)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:EMULSION;TOPICALStrength3%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Boehringer Ingelheim
McKinsey
Deloitte
Cipla
Healthtrust
Mallinckrodt
Novartis
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot